ProShare Advisors’s Kiniksa Pharmaceuticals KNSA Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-10,225
| Closed | -$227K | – | 2134 |
|
|
2025
Q1 | $227K | Sell |
10,225
-2,582
| -20% | -$57.3K | ﹤0.01% | 1602 |
|
|
2024
Q4 | $253K | Buy |
12,807
+3,357
| +36% | +$66.4K | ﹤0.01% | 1759 |
|
|
2024
Q3 | $236K | Buy |
+9,450
| New | +$236K | ﹤0.01% | 1631 |
|
|
2022
Q1 | – | Sell |
-11,143
| Closed | -$131K | – | 2255 |
|
|
2021
Q4 | $131K | Buy |
11,143
+433
| +4% | +$5.09K | ﹤0.01% | 2156 |
|
|
2021
Q3 | $122K | Sell |
10,710
-2,664
| -20% | -$30.3K | ﹤0.01% | 1884 |
|
|
2021
Q2 | $186K | Buy |
13,374
+1,814
| +16% | +$25.2K | ﹤0.01% | 2166 |
|
|
2021
Q1 | $214K | Buy |
11,560
+754
| +7% | +$14K | ﹤0.01% | 2001 |
|
|
2020
Q4 | $191K | Buy |
+10,806
| New | +$191K | ﹤0.01% | 1858 |
|